Yesol Yim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yesol Yim has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Dong Keon Yon
Department of Medicine Kyung Hee University College of Medicine Seoul South Korea
10 shared publications - Ho Geol Woo
Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea
5 shared publications Hyunjee Kim
Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea
5 shared publications- Jaeyu Park
Center for Digital Health, Medical Science Research Institute Kyung Hee University Medical Center, Kyung Hee University College of Medicine Seoul South Korea
5 shared publications - Lee Smith
Centre for Health, Performance and Wellbeing Anglia Ruskin University Cambridge UK
4 shared publications - Yejun Son
Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea
4 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (41) , e51053
National trends in chronic kidney disease prevalence by sleep duration in South Korea, 2007 to 2022
Despite growing evidence linking sleep duration to chronic kidney disease (CKD), long-term trend analyses specific to the Korean population remain limited, and most previous studies have relied on broad intermediate sleep categories. This study analyzed trends in CKD prevalence by self-reported sleep duration among Korean adults. We included 87,246 Korean adults aged ≥19 years from the Korea National Health and Nutrition Examination Survey, 2007 to 2022. CKD was defined as an estimated glomerular filtration rate 2 . Sleep duration was categorized into 5 groups (<6, 6–7, 7–8, 8–9, and ≥9 hours), with 7 to 8 hours as the reference. Weighted linear and logistic regression models provided β-coefficients and weighted odds ratios with 95% confidence intervals, sequentially adjusted for age, sex, body mass index, region, household income, education, smoking status, physician-diagnosed diabetes mellitus, hypertension, and dyslipidemia, and perceived stress. CKD prevalence declined across all 5 categories from 2007 to 2009 to 2020 to 2022 (<6 hours, 5.13% [95% confidence intervals, 4.12–6.13]–3.53% [2.74–4.33]; 7 to 8 hours, 2.37% [1.82–2.93]–1.52% [1.16–1.89]; ≥9 hours, 4.33% [3.17–5.48]–2.95% [2.18–3.72]). A U-shaped association was observed: relative to 7 to 8 hours, the fully adjusted odds of CKD were higher for .05). In conclusion, CKD prevalence showed a U-shaped association with sleep duration that persisted after adjustment for cardiometabolic comorbidity and perceived stress. The absence of a significant change across the pandemic threshold should be interpreted in light of the short observation window relative to the natural history of CKD.
- 9 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (41) , e51053
Open AccessNational trends in chronic kidney disease prevalence by sleep duration in South Korea, 2007 to 2022
Despite growing evidence linking sleep duration to chronic kidney disease (CKD), long-term trend analyses specific to the Korean population remain limited, and most previous studies have relied on broad intermediate sleep categories. This study analyzed trends in CKD prevalence by self-reported sleep duration among Korean adults. We included 87,246 Korean adults aged ≥19 years from the Korea National Health and Nutrition Examination Survey, 2007 to 2022. CKD was defined as an estimated glomerular filtration rate 2 . Sleep duration was categorized into 5 groups (<6, 6–7, 7–8, 8–9, and ≥9 hours), with 7 to 8 hours as the reference. Weighted linear and logistic regression models provided β-coefficients and weighted odds ratios with 95% confidence intervals, sequentially adjusted for age, sex, body mass index, region, household income, education, smoking status, physician-diagnosed diabetes mellitus, hypertension, and dyslipidemia, and perceived stress. CKD prevalence declined across all 5 categories from 2007 to 2009 to 2020 to 2022 (<6 hours, 5.13% [95% confidence intervals, 4.12–6.13]–3.53% [2.74–4.33]; 7 to 8 hours, 2.37% [1.82–2.93]–1.52% [1.16–1.89]; ≥9 hours, 4.33% [3.17–5.48]–2.95% [2.18–3.72]). A U-shaped association was observed: relative to 7 to 8 hours, the fully adjusted odds of CKD were higher for .05). In conclusion, CKD prevalence showed a U-shaped association with sleep duration that persisted after adjustment for cardiometabolic comorbidity and perceived stress. The absence of a significant change across the pandemic threshold should be interpreted in light of the short observation window relative to the natural history of CKD.
- Open Access
- 17 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (16) , e48127
Long-term trends of lipid concentrations and lipid control in South Korea, 2007 to 2023: A nationwide representative study
Long-term trend studies on lipid concentrations and lipid control among Korean adults up to 2023 are limited. Therefore, this study aimed to assess nationwide trends in lipid concentrations and lipid control, including subgroup disparities, over a 17-year period. We used nationally representative data from the Korea National Health and Nutrition Examination Survey from 2007 to 2023. Lipid control was defined as total cholesterol (TC) <200 mg/dL among lipid-lowering medication users. Primary outcomes were age-standardized blood concentrations of TC, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), and the proportion achieving lipid control. Survey-weighted linear regression was used to estimate mean differences in lipid concentrations with 95% confidence intervals (CIs), and survey-weighted logistic regression was applied to assess subgroup differences in lipid control. A total of 97,129 nonpregnant adults aged ≥20 years were included in the analyses (female, 56.69%). Age-standardized mean TC levels increased in the overall population, from 184.7 mg/dL (95% CI, 183.8–185.6) in 2007–2009 to 189.7 mg/dL (188.6–190.7) in 2022–2023 (mean difference, 5.0 mg/dL [3.6–6.3]). In contrast, HDL-C improved, LDL-C declined, and TG levels showed no significant change. Among lipid-lowering medication users, mean TC decreased from 164.1 mg/dL (95% CI, 161.3–167.0) in 2007–2009 to 152.2 mg/dL (150.8–153.6) in 2022–2023, and lipid control rates increased from 72.97% (67.99–77.95) to 88.09% (86.33–89.85), respectively. However, several groups had significantly lower odds of lipid control: adults aged 20 to 44 years (weighted odds ratio, 0.39 [95% CI, 0.26–0.57]), individuals with high school education or less (0.82 [0.70–0.95]), and those with insufficient muscle strengthening exercise (0.75 [0.59–0.96]), compared with their respective reference groups. Lipid concentrations in Korean adults improved from 2007–2009 to 2022–2023, characterized by lower LDL-C, higher HDL-C, and stable TG levels. Lipid control among adults receiving lipid-lowering therapy also increased steadily over 17 years. However, disparities among younger adults and those with lower education underscore the need for targeted strategies to achieve more equitable improvements in lipid control.
- 17 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (16) , e48127
Open AccessLong-term trends of lipid concentrations and lipid control in South Korea, 2007 to 2023: A nationwide representative study
Long-term trend studies on lipid concentrations and lipid control among Korean adults up to 2023 are limited. Therefore, this study aimed to assess nationwide trends in lipid concentrations and lipid control, including subgroup disparities, over a 17-year period. We used nationally representative data from the Korea National Health and Nutrition Examination Survey from 2007 to 2023. Lipid control was defined as total cholesterol (TC) <200 mg/dL among lipid-lowering medication users. Primary outcomes were age-standardized blood concentrations of TC, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), and the proportion achieving lipid control. Survey-weighted linear regression was used to estimate mean differences in lipid concentrations with 95% confidence intervals (CIs), and survey-weighted logistic regression was applied to assess subgroup differences in lipid control. A total of 97,129 nonpregnant adults aged ≥20 years were included in the analyses (female, 56.69%). Age-standardized mean TC levels increased in the overall population, from 184.7 mg/dL (95% CI, 183.8–185.6) in 2007–2009 to 189.7 mg/dL (188.6–190.7) in 2022–2023 (mean difference, 5.0 mg/dL [3.6–6.3]). In contrast, HDL-C improved, LDL-C declined, and TG levels showed no significant change. Among lipid-lowering medication users, mean TC decreased from 164.1 mg/dL (95% CI, 161.3–167.0) in 2007–2009 to 152.2 mg/dL (150.8–153.6) in 2022–2023, and lipid control rates increased from 72.97% (67.99–77.95) to 88.09% (86.33–89.85), respectively. However, several groups had significantly lower odds of lipid control: adults aged 20 to 44 years (weighted odds ratio, 0.39 [95% CI, 0.26–0.57]), individuals with high school education or less (0.82 [0.70–0.95]), and those with insufficient muscle strengthening exercise (0.75 [0.59–0.96]), compared with their respective reference groups. Lipid concentrations in Korean adults improved from 2007–2009 to 2022–2023, characterized by lower LDL-C, higher HDL-C, and stable TG levels. Lipid control among adults receiving lipid-lowering therapy also increased steadily over 17 years. However, disparities among younger adults and those with lower education underscore the need for targeted strategies to achieve more equitable improvements in lipid control.
- Open Access
- 27 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (9) , e47797
National trends of metabolically healthy and unhealthy obesity before and during the COVID-19 pandemic, 2007 to 2021: A representative serial study in South Korea
Long-term, nationally representative trends in metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO) in South Korea remain limited. Thus, we aimed to analyze the prevalence trends of MHO and MUHO and compare rates before and during the coronavirus disease 2019 (COVID-19) pandemic. We analyzed adults aged ≥ 19 years from the Korea National Health and Nutrition Examination Survey (2007–2021), a nationally representative repeated cross-sectional survey. Obese adults were classified as MHO or MUHO using National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) guidelines. To assess pandemic impact, data were divided into before (2007–2019) and during (2020–2021) the pandemic. National prevalence and temporal changes were estimated using weighted linear and logistic regression with 95% confidence intervals (CIs). A total of 87,625 adults were included (56.51% female). MUHO prevalence consistently exceeded MHO across all years. In 2021, MHO prevalence was 3.63% (95% CI = 2.97–4.28) versus 15.02% (13.05–16.99) for MUHO. Before the pandemic, MHO prevalence increased steadily (β = 0.035 [95% CI = 0.016–0.055]) and continued to rise during the pandemic (β = 0.055 [0.006–0.104]). MUHO prevalence, however, grew more sharply before the pandemic (β = 0.073 [0.036–0.111]) but plateaued during the pandemic (β = 0.061 [–0.031 to 0.153]). This nationwide cross-sectional study highlights distinct trajectories of MHO and MUHO before and during COVID-19. Given the higher and persistent prevalence of MUHO, personalized strategies tailored to metabolic health status are essential in managing obesity in Korea, with important implications for public health policy development.
- 27 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (9) , e47797
Open AccessNational trends of metabolically healthy and unhealthy obesity before and during the COVID-19 pandemic, 2007 to 2021: A representative serial study in South Korea
Long-term, nationally representative trends in metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO) in South Korea remain limited. Thus, we aimed to analyze the prevalence trends of MHO and MUHO and compare rates before and during the coronavirus disease 2019 (COVID-19) pandemic. We analyzed adults aged ≥ 19 years from the Korea National Health and Nutrition Examination Survey (2007–2021), a nationally representative repeated cross-sectional survey. Obese adults were classified as MHO or MUHO using National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) guidelines. To assess pandemic impact, data were divided into before (2007–2019) and during (2020–2021) the pandemic. National prevalence and temporal changes were estimated using weighted linear and logistic regression with 95% confidence intervals (CIs). A total of 87,625 adults were included (56.51% female). MUHO prevalence consistently exceeded MHO across all years. In 2021, MHO prevalence was 3.63% (95% CI = 2.97–4.28) versus 15.02% (13.05–16.99) for MUHO. Before the pandemic, MHO prevalence increased steadily (β = 0.035 [95% CI = 0.016–0.055]) and continued to rise during the pandemic (β = 0.055 [0.006–0.104]). MUHO prevalence, however, grew more sharply before the pandemic (β = 0.073 [0.036–0.111]) but plateaued during the pandemic (β = 0.061 [–0.031 to 0.153]). This nationwide cross-sectional study highlights distinct trajectories of MHO and MUHO before and during COVID-19. Given the higher and persistent prevalence of MUHO, personalized strategies tailored to metabolic health status are essential in managing obesity in Korea, with important implications for public health policy development.
- Open Access
- 30 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (5) , e47462
Binational component-wise association between cardiovascular-kidney-metabolic syndrome and life’s essential 8 in South Korea and the US: A nationally representative comparative study
Although the American Heart Association (AHA) has emphasized the integration of cardiovascular-kidney-metabolic (CKM) syndrome and life’s essential 8 (LE8) score, research on their association remains limited. To address this gap, this study analyzed the component-wise association between CKM syndrome and LE8 scores using nationally representative data from South Korea and the US. This binational study included adults aged 30 to 79 years from the Korea National Health and Nutrition Examination Surveys 2013 to 2020 and the US National Health and Nutrition Examination Surveys 2013 to 2020. CKM stages and LE8 scores were defined according to AHA criteria. LE8 scores encompass 4 health behaviors (diet, physical activity, nicotine exposure, and sleep) and 4 health factors (body mass index, blood lipids, blood glucose, and blood pressure). All analyses accounted for the complex survey design through appropriate sampling weights, stratification, and clustering methods. Associations between LE8 scores and the prevalence of CKM syndrome were assessed using weighted logistic regression adjusted for age, sex, household income, education level, and alcohol consumption. We included 8150 Koreans, the Korea National Health and Nutrition Examination Survey (61.30% female), and 5859 American participants (National Health and Nutrition Examination Survey; 44.80% female) aged 30 to 79. Higher LE8 scores were consistently associated with a lower prevalence of CKM syndrome in both Korea and the US. In Korea, component-wise association was primarily explained by health factor scores (weighted odds ratio [wOR], 0.09; 95% confidence interval, 0.06–0.14), whereas in the US, health behavior scores reported a distinct association (0.30; 0.17–0.52). Among all age groups, the protective association between LE8 scores and CKM syndrome was most pronounced in adults aged 30 to 44 years, with wORs of 0.89 (0.85–0.93) in Korea and 0.93 (0.91–0.95) in the US. This binational study highlights the importance of country-specific intervention strategies in reducing the burden of CKM syndrome. The findings of this study may provide a basis for designing targeted public health interventions aimed at CKM syndrome.
- 30 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (5) , e47462
Open AccessBinational component-wise association between cardiovascular-kidney-metabolic syndrome and life’s essential 8 in South Korea and the US: A nationally representative comparative study
Although the American Heart Association (AHA) has emphasized the integration of cardiovascular-kidney-metabolic (CKM) syndrome and life’s essential 8 (LE8) score, research on their association remains limited. To address this gap, this study analyzed the component-wise association between CKM syndrome and LE8 scores using nationally representative data from South Korea and the US. This binational study included adults aged 30 to 79 years from the Korea National Health and Nutrition Examination Surveys 2013 to 2020 and the US National Health and Nutrition Examination Surveys 2013 to 2020. CKM stages and LE8 scores were defined according to AHA criteria. LE8 scores encompass 4 health behaviors (diet, physical activity, nicotine exposure, and sleep) and 4 health factors (body mass index, blood lipids, blood glucose, and blood pressure). All analyses accounted for the complex survey design through appropriate sampling weights, stratification, and clustering methods. Associations between LE8 scores and the prevalence of CKM syndrome were assessed using weighted logistic regression adjusted for age, sex, household income, education level, and alcohol consumption. We included 8150 Koreans, the Korea National Health and Nutrition Examination Survey (61.30% female), and 5859 American participants (National Health and Nutrition Examination Survey; 44.80% female) aged 30 to 79. Higher LE8 scores were consistently associated with a lower prevalence of CKM syndrome in both Korea and the US. In Korea, component-wise association was primarily explained by health factor scores (weighted odds ratio [wOR], 0.09; 95% confidence interval, 0.06–0.14), whereas in the US, health behavior scores reported a distinct association (0.30; 0.17–0.52). Among all age groups, the protective association between LE8 scores and CKM syndrome was most pronounced in adults aged 30 to 44 years, with wORs of 0.89 (0.85–0.93) in Korea and 0.93 (0.91–0.95) in the US. This binational study highlights the importance of country-specific intervention strategies in reducing the burden of CKM syndrome. The findings of this study may provide a basis for designing targeted public health interventions aimed at CKM syndrome.
- Open Access
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47143
National trends of unmet healthcare needs and risk factors by household income level, 2010 to 2022: A Nationwide cross-sectional study in South Korea
Socio-economic status plays a critical role in shaping unmet healthcare needs, and the COVID-19 pandemic has further intensified these disparities; however, research to date remains insufficient. Therefore, this study aims to analyze unmet healthcare needs by household income using large-scale longitudinal data (2010–2022) including pre- and post- pandemic differences. This large-scale study (n = 2,628,584) utilized nationwide data from the Korea Community Health Survey (KCHS) conducted between 2010 and 2022, administered by the Korea Disease Control and Prevention Agency. The analysis employed complex, weighted sampling to examine trends in unmet healthcare needs, with a specific focus on changes during the COVID-19 pandemic. Weighted logistic regression models were used to calculate odds ratios and β differences (β diff ) between the pre-pandemic (2010–2019) and pandemic (2020–2022) periods. In total, 2,628,584 individuals participated in the KCHS from 2010 to 2022, comprising 1,454,129 males (55.3%) and 1,174,455 females (44.7%). Before the pandemic, there was a consistent decline in the prevalence of unmet healthcare needs. However, following the onset of the pandemic, unmet healthcare needs increased (β diff, low-level of household income: 1.66 [95% CI, 1.41–1.92]; mid-level of household income: 0.88 [95% CI, 0.77–0.99]; high-level of household income: 0.71 [95% CI, 0.57–0.85]). Overall, households with lower incomes exhibited higher levels of unmet healthcare needs compared to those with higher incomes (low household income: 14.8 [95% CI, 13.91–14.24]; high household income: 8.45 [95% CI, 8.34–8.55]). Additionally, the disparity in healthcare access due to income differences was more pronounced among older individuals, those with lower educational attainment, and those with lower subjective health status. Our analysis found that older adults in low-income households consistently faced higher rates of unmet healthcare needs. The reversal of a pre-pandemic trend toward reducing healthcare gaps highlights the urgent need for targeted interventions to address socio-economic disparities.
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47143
Open AccessNational trends of unmet healthcare needs and risk factors by household income level, 2010 to 2022: A Nationwide cross-sectional study in South Korea
Socio-economic status plays a critical role in shaping unmet healthcare needs, and the COVID-19 pandemic has further intensified these disparities; however, research to date remains insufficient. Therefore, this study aims to analyze unmet healthcare needs by household income using large-scale longitudinal data (2010–2022) including pre- and post- pandemic differences. This large-scale study (n = 2,628,584) utilized nationwide data from the Korea Community Health Survey (KCHS) conducted between 2010 and 2022, administered by the Korea Disease Control and Prevention Agency. The analysis employed complex, weighted sampling to examine trends in unmet healthcare needs, with a specific focus on changes during the COVID-19 pandemic. Weighted logistic regression models were used to calculate odds ratios and β differences (β diff ) between the pre-pandemic (2010–2019) and pandemic (2020–2022) periods. In total, 2,628,584 individuals participated in the KCHS from 2010 to 2022, comprising 1,454,129 males (55.3%) and 1,174,455 females (44.7%). Before the pandemic, there was a consistent decline in the prevalence of unmet healthcare needs. However, following the onset of the pandemic, unmet healthcare needs increased (β diff, low-level of household income: 1.66 [95% CI, 1.41–1.92]; mid-level of household income: 0.88 [95% CI, 0.77–0.99]; high-level of household income: 0.71 [95% CI, 0.57–0.85]). Overall, households with lower incomes exhibited higher levels of unmet healthcare needs compared to those with higher incomes (low household income: 14.8 [95% CI, 13.91–14.24]; high household income: 8.45 [95% CI, 8.34–8.55]). Additionally, the disparity in healthcare access due to income differences was more pronounced among older individuals, those with lower educational attainment, and those with lower subjective health status. Our analysis found that older adults in low-income households consistently faced higher rates of unmet healthcare needs. The reversal of a pre-pandemic trend toward reducing healthcare gaps highlights the urgent need for targeted interventions to address socio-economic disparities.
- Open Access
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47365
Association between blood heavy metal levels and subtypes of steatotic liver disease: A nationally representative cross-sectional analysis in South Korea
Most prior studies have investigated the association between heavy metals and nonalcoholic fatty liver disease as a single entity; however, there is limited evidence regarding subtype-specific associations with steatotic liver disease (SLD) as defined by the new criteria. Thus, this study investigates associations between blood levels of heavy metals and SLD subtypes using nationally representative data from South Korea. Data were obtained from the Korea National Health and Nutrition Examination Survey between 2005 and 2017, including adults aged 19 years and older. Blood levels of heavy metals, including lead (Pb), mercury (Hg), and cadmium (Cd), were examined. SLD, estimated using the hepatic steatosis index with alcohol consumption, was categorized into metabolic dysfunction–associated SLD (MASLD), metabolic alcohol-related liver disease (MetALD), and alcohol-related liver disease (ALD). Weighted logistic regression was used to assess the association between blood concentrations of Pb, Hg, and Cd and the prevalence of each SLD subtype. The associations with metabolic biomarkers were evaluated using a weighted generalized linear model, and subgroup analyses were conducted by sex. A total of 18,871 adults (9117 males [48.31%]) with available heavy metal-related data were included in the analysis. Blood Pb levels were associated with a decreased risk of MASLD (adjusted odds ratio [aOR], 0.90 [95% CI: 0.86–0.95]) but an increased risk of ALD (1.21 [1.15–1.27]). Blood Hg level was associated with MASLD (1.03 [95% CI: 1.01–1.04]), MetALD (1.07 [1.05–1.09]), and ALD (1.02 [1.01–1.03]), with a linear trend in disease risk across quartiles. Blood Cd level showed no associations overall but was significantly associated with MetALD (1.59 [95% CI: 1.11–2.27]) and ALD (1.52 [1.24–1.85]) in male only. Both blood Hg and Cd levels were positively associated with liver enzymes and metabolic parameters. This first nationally representative study using the new classification highlights the subtype-specific impact of heavy metals on SLD. The findings suggest Hg and Cd link metabolic dysfunction to liver disease, underscoring the need for subtype-tailored environmental risk assessments and precision public health strategies.
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47365
Open AccessAssociation between blood heavy metal levels and subtypes of steatotic liver disease: A nationally representative cross-sectional analysis in South Korea
Most prior studies have investigated the association between heavy metals and nonalcoholic fatty liver disease as a single entity; however, there is limited evidence regarding subtype-specific associations with steatotic liver disease (SLD) as defined by the new criteria. Thus, this study investigates associations between blood levels of heavy metals and SLD subtypes using nationally representative data from South Korea. Data were obtained from the Korea National Health and Nutrition Examination Survey between 2005 and 2017, including adults aged 19 years and older. Blood levels of heavy metals, including lead (Pb), mercury (Hg), and cadmium (Cd), were examined. SLD, estimated using the hepatic steatosis index with alcohol consumption, was categorized into metabolic dysfunction–associated SLD (MASLD), metabolic alcohol-related liver disease (MetALD), and alcohol-related liver disease (ALD). Weighted logistic regression was used to assess the association between blood concentrations of Pb, Hg, and Cd and the prevalence of each SLD subtype. The associations with metabolic biomarkers were evaluated using a weighted generalized linear model, and subgroup analyses were conducted by sex. A total of 18,871 adults (9117 males [48.31%]) with available heavy metal-related data were included in the analysis. Blood Pb levels were associated with a decreased risk of MASLD (adjusted odds ratio [aOR], 0.90 [95% CI: 0.86–0.95]) but an increased risk of ALD (1.21 [1.15–1.27]). Blood Hg level was associated with MASLD (1.03 [95% CI: 1.01–1.04]), MetALD (1.07 [1.05–1.09]), and ALD (1.02 [1.01–1.03]), with a linear trend in disease risk across quartiles. Blood Cd level showed no associations overall but was significantly associated with MetALD (1.59 [95% CI: 1.11–2.27]) and ALD (1.52 [1.24–1.85]) in male only. Both blood Hg and Cd levels were positively associated with liver enzymes and metabolic parameters. This first nationally representative study using the new classification highlights the subtype-specific impact of heavy metals on SLD. The findings suggest Hg and Cd link metabolic dysfunction to liver disease, underscoring the need for subtype-tailored environmental risk assessments and precision public health strategies.
- Open Access
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e45960
Cardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002–2022: A population-based cohort study
Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging global framework, but evidence on stage-specific cardiovascular risks remains limited. Therefore, we investigated the association between CKM syndrome stages and cardiovascular outcomes, accounting for confounders and identifying the most influential components. This study utilized data from the Ansan – Ansung cohort, a longitudinal population-based cohort study conducted in South Korea from 2002 to 2022. CKM syndrome was classified according to the American Heart Association guidelines using the Predicting Risk of Cardiovascular Disease EVENTs equations into 4 stages: stage 0 (healthy), stage 1 (early risk), stage 2 (intermediate risk), and stage 3 (severe). A Cox proportional hazards model with time-varying covariates was applied to evaluate the associations between CKM syndrome stages and cardiovascular outcomes, including cerebrovascular disease, coronary artery disease, and myocardial infarction. Among the 9373 participants (47.2% male), 1074 (11.5%) were in stage 0, 1919 (20.5%) in stage 1, 3791 (40.5%) in stage 2, and 2589 (27.6%) in stage 3. Compared with stage 0, the risk of cardiovascular diseases was significantly increased in stage 2 (adjusted hazard ratio, 1.18 [95% confidence interval 1.03–1.38]) and stage 3 (1.26 [1.05–1.50]), whereas stage 1 showed no significant association. Among the underlying CKM conditions, hypertension exhibited the strongest association with all 3 outcomes: cerebrovascular disease (1.50 [1.34–1.67]), coronary artery disease (1.40 [1.22–1.60]), and myocardial infarction (1.43 [1.18–1.75]). Overall, this cohort study indicates that higher CKM syndrome stages are associated with increased cardiovascular risks. These findings underscore the importance of comprehensive, multidisciplinary strategies in clinical management and public health policies to reduce the burden of CKM syndrome and its related cardiovascular risks.
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e45960
Open AccessCardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002–2022: A population-based cohort study
Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging global framework, but evidence on stage-specific cardiovascular risks remains limited. Therefore, we investigated the association between CKM syndrome stages and cardiovascular outcomes, accounting for confounders and identifying the most influential components. This study utilized data from the Ansan – Ansung cohort, a longitudinal population-based cohort study conducted in South Korea from 2002 to 2022. CKM syndrome was classified according to the American Heart Association guidelines using the Predicting Risk of Cardiovascular Disease EVENTs equations into 4 stages: stage 0 (healthy), stage 1 (early risk), stage 2 (intermediate risk), and stage 3 (severe). A Cox proportional hazards model with time-varying covariates was applied to evaluate the associations between CKM syndrome stages and cardiovascular outcomes, including cerebrovascular disease, coronary artery disease, and myocardial infarction. Among the 9373 participants (47.2% male), 1074 (11.5%) were in stage 0, 1919 (20.5%) in stage 1, 3791 (40.5%) in stage 2, and 2589 (27.6%) in stage 3. Compared with stage 0, the risk of cardiovascular diseases was significantly increased in stage 2 (adjusted hazard ratio, 1.18 [95% confidence interval 1.03–1.38]) and stage 3 (1.26 [1.05–1.50]), whereas stage 1 showed no significant association. Among the underlying CKM conditions, hypertension exhibited the strongest association with all 3 outcomes: cerebrovascular disease (1.50 [1.34–1.67]), coronary artery disease (1.40 [1.22–1.60]), and myocardial infarction (1.43 [1.18–1.75]). Overall, this cohort study indicates that higher CKM syndrome stages are associated with increased cardiovascular risks. These findings underscore the importance of comprehensive, multidisciplinary strategies in clinical management and public health policies to reduce the burden of CKM syndrome and its related cardiovascular risks.
- Open Access
- 5 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (49) , e46295
Long-term trends in anemia prevalence before and after COVID-19 among non-pregnant adults in South Korea, 2010 to 2023
Anemia is a global public health concern, yet its long-term trends in the general adult population, particularly during the COVID-19 pandemic, remain unclear. This study analyzed long-term trends and risk factors for anemia among non-pregnant adults including the pandemic. We analyzed data from the Korea National Health and Nutrition Examination Survey conducted on non-pregnant adults. Anemia was defined as a hemoglobin level of <13 g/dL in males and <12 g/dL in females. The prevalence of anemia was assessed across the pre- (2010–2019), intra- (2020–2022), and post-pandemic (2023) using a weighted linear regression, and risk factors were evaluated using multivariable weighted logistic regression. About 68,696 non-pregnant adults (29,074 males [42.32%]) were included in the analysis from 2010 to 2023. The prevalence of anemia showed an increasing trend from 8.49% (95% confidence interval [CI], 8.20–8.78) in pre-pandemic to 11.23% (10.61–11.86) in intra-pandemic and 11.93% (10.86–13.00) in post-pandemic. A significant rise was observed during the intra-pandemic period, with adjusted odds ratio of 1.37 (95% CI: 1.21–1.56) compared to pre-pandemic years. Anemia prevalence tended to rise with age in males, whereas it reached its lowest point in females aged 50 to 59 years. Key risk factors included female sex, older age, underweight, lower household income, and no dietary supplement use. Anemia prevalence has risen steadily over the past decade and further escalated during the COVID-19 pandemic. Although sex-based patterns followed overall patterns, age-related trends varied by sex. These results emphasize the need for age- and sex-specific public health strategies and targeted interventions for vulnerable groups.
- 5 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (49) , e46295
Open AccessLong-term trends in anemia prevalence before and after COVID-19 among non-pregnant adults in South Korea, 2010 to 2023
Anemia is a global public health concern, yet its long-term trends in the general adult population, particularly during the COVID-19 pandemic, remain unclear. This study analyzed long-term trends and risk factors for anemia among non-pregnant adults including the pandemic. We analyzed data from the Korea National Health and Nutrition Examination Survey conducted on non-pregnant adults. Anemia was defined as a hemoglobin level of <13 g/dL in males and <12 g/dL in females. The prevalence of anemia was assessed across the pre- (2010–2019), intra- (2020–2022), and post-pandemic (2023) using a weighted linear regression, and risk factors were evaluated using multivariable weighted logistic regression. About 68,696 non-pregnant adults (29,074 males [42.32%]) were included in the analysis from 2010 to 2023. The prevalence of anemia showed an increasing trend from 8.49% (95% confidence interval [CI], 8.20–8.78) in pre-pandemic to 11.23% (10.61–11.86) in intra-pandemic and 11.93% (10.86–13.00) in post-pandemic. A significant rise was observed during the intra-pandemic period, with adjusted odds ratio of 1.37 (95% CI: 1.21–1.56) compared to pre-pandemic years. Anemia prevalence tended to rise with age in males, whereas it reached its lowest point in females aged 50 to 59 years. Key risk factors included female sex, older age, underweight, lower household income, and no dietary supplement use. Anemia prevalence has risen steadily over the past decade and further escalated during the COVID-19 pandemic. Although sex-based patterns followed overall patterns, age-related trends varied by sex. These results emphasize the need for age- and sex-specific public health strategies and targeted interventions for vulnerable groups.
- Open Access
- 21 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (47) , e46042
National trends in the prevalence of hypertension and diabetes stratified by sleep duration in South Korea, 2009–2022: A nationwide cross-sectional study: Trends and association of sleep duration in hypertension and diabetes
The increase in sleep-related issues is associated with various health problems, particularly hypertension and diabetes. Therefore, this study aims to address these gaps in the literature by analyzing the relationship between sleep duration and the prevalence of hypertension and diabetes. This study analyzed the association between hypertension, diabetes, and sleep duration using the Korea Community Health Survey database from 2009 to 2022. The study used weighted linear regression models to identify trends in diseases and sleep duration. Additionally, this analysis employed weighted logistic regression to examine associations between diseases and covariates, presented as weighted odds ratio (wOR) and 95% confidence intervals (CIs). Our analysis included 2,903,887 individuals aged ≥19 years. The prevalence of individuals with both hypertension and diabetes increased before (β, 0.87 [95% CI, 0.83–0.90]) and during the COVID-19 pandemic (β, 0.64 [0.58–0.70]). This trend was particularly notable among individuals who sleep less than 6 hours, with an increase identified both before (β, 1.28 [1.16–1.40]) and during the pandemic (β, 1.21 [1.03–1.39]). The higher risk of having both conditions was found in individuals who slept 8 hours (wOR, 1.19 [1.17–1.22]) compared to those who slept 7 to 8 hours. Our study is the first to analyze the association between sleep duration and hypertension and diabetes by utilizing a large-scale dataset and conducting a comparative analysis between the pre-COVID-19 and COVID-19 periods. This study shows that inadequate sleep is associated with an increased risk of hypertension and diabetes.
- 21 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (47) , e46042
Open AccessNational trends in the prevalence of hypertension and diabetes stratified by sleep duration in South Korea, 2009–2022: A nationwide cross-sectional study: Trends and association of sleep duration in hypertension and diabetes
The increase in sleep-related issues is associated with various health problems, particularly hypertension and diabetes. Therefore, this study aims to address these gaps in the literature by analyzing the relationship between sleep duration and the prevalence of hypertension and diabetes. This study analyzed the association between hypertension, diabetes, and sleep duration using the Korea Community Health Survey database from 2009 to 2022. The study used weighted linear regression models to identify trends in diseases and sleep duration. Additionally, this analysis employed weighted logistic regression to examine associations between diseases and covariates, presented as weighted odds ratio (wOR) and 95% confidence intervals (CIs). Our analysis included 2,903,887 individuals aged ≥19 years. The prevalence of individuals with both hypertension and diabetes increased before (β, 0.87 [95% CI, 0.83–0.90]) and during the COVID-19 pandemic (β, 0.64 [0.58–0.70]). This trend was particularly notable among individuals who sleep less than 6 hours, with an increase identified both before (β, 1.28 [1.16–1.40]) and during the pandemic (β, 1.21 [1.03–1.39]). The higher risk of having both conditions was found in individuals who slept 8 hours (wOR, 1.19 [1.17–1.22]) compared to those who slept 7 to 8 hours. Our study is the first to analyze the association between sleep duration and hypertension and diabetes by utilizing a large-scale dataset and conducting a comparative analysis between the pre-COVID-19 and COVID-19 periods. This study shows that inadequate sleep is associated with an increased risk of hypertension and diabetes.
- Open Access
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43773
National trends in hypertension stratified by central adiposity using waist-to-height ratio in South Korea, 2005 to 2022
Despite the growing prevalence of hypertension due to lifestyle changes and aging populations, with central obesity as a critical risk factor, there is limited research examining the association between central adiposity and hypertension trends. To address this gap, this study analyzed trends in hypertension prevalence among Korean adults categorized by healthy and increased central adiposity based on waist-to-height ratio (WHtR) and investigated the associated risk factors. We utilized data from 98,396 adults aged 30 years and older from the Korea National Health and Nutrition Examination Survey from 2005 to 2022 in South Korea. Participants were categorized into 2 groups according to central adiposity: low-WHtR group (diff , and adjusted odds ratios with 95% confidence intervals. From 2005 to 2019, the prevalence of hypertension increased in both low and high-WHtR groups, with a more pronounced increase in the increased central obesity group. Notably, the prevalence was higher in males than in females in the low-WHtR group (20.47% in males vs 12.33% in females), but similar in both sexes in the high-WHtR group (43.44% vs 41.74%). Furthermore, subgroup analyses showed that females aged 30–59 years in the high-WHtR group had higher odds of hypertension than males, whereas males aged 60 years and older had higher odds than females. This study suggests that the association between central obesity and hypertension risk varies significantly across age and sex categories, highlighting the necessity for age- and sex-specific prevention and management strategies.
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43773
Open AccessNational trends in hypertension stratified by central adiposity using waist-to-height ratio in South Korea, 2005 to 2022
Despite the growing prevalence of hypertension due to lifestyle changes and aging populations, with central obesity as a critical risk factor, there is limited research examining the association between central adiposity and hypertension trends. To address this gap, this study analyzed trends in hypertension prevalence among Korean adults categorized by healthy and increased central adiposity based on waist-to-height ratio (WHtR) and investigated the associated risk factors. We utilized data from 98,396 adults aged 30 years and older from the Korea National Health and Nutrition Examination Survey from 2005 to 2022 in South Korea. Participants were categorized into 2 groups according to central adiposity: low-WHtR group (diff , and adjusted odds ratios with 95% confidence intervals. From 2005 to 2019, the prevalence of hypertension increased in both low and high-WHtR groups, with a more pronounced increase in the increased central obesity group. Notably, the prevalence was higher in males than in females in the low-WHtR group (20.47% in males vs 12.33% in females), but similar in both sexes in the high-WHtR group (43.44% vs 41.74%). Furthermore, subgroup analyses showed that females aged 30–59 years in the high-WHtR group had higher odds of hypertension than males, whereas males aged 60 years and older had higher odds than females. This study suggests that the association between central obesity and hypertension risk varies significantly across age and sex categories, highlighting the necessity for age- and sex-specific prevention and management strategies.